Evidence map›Paper›PMID 39085733›Full record

Observational studyAging clinical and experimental research2024

Influence of serum uric acid on bone and fracture risk in postmenopausal women.

María-Jesús Gómez-de-Tejada-Romero, Carmen Murias-Henríquez, Pedro Saavedra-Santana, Nery Sablón-González, Delvys Rodríguez Abreu, Manuel Sosa-Henríquez

Abstract readObservational Study
In one paragraph

Observational study in Aging clinical and experimental research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

María-Jesús Gómez-de-Tejada-RomeroDepartment of Medicine, University of Seville, Seville, Spain.
Carmen Murias-HenríquezUniversity of Las Palmas de Gran Canaria, Osteoporosis and Mineral Metabolism Research Group. Las Palmas de Gran Canaria, Canaria, Spain.
Pedro Saavedra-SantanaUniversity of Las Palmas de Gran Canaria, Osteoporosis and Mineral Metabolism Research Group. Las Palmas de Gran Canaria, Canaria, Spain.
Nery Sablón-GonzálezUniversity of Las Palmas de Gran Canaria, Osteoporosis and Mineral Metabolism Research Group. Las Palmas de Gran Canaria, Canaria, Spain.
Delvys Rodríguez AbreuUniversity of Las Palmas de Gran Canaria, Osteoporosis and Mineral Metabolism Research Group. Las Palmas de Gran Canaria, Canaria, Spain.
Manuel Sosa-HenríquezUniversity of Las Palmas de Gran Canaria, Osteoporosis and Mineral Metabolism Research Group. Las Palmas de Gran Canaria, Canaria, Spain. manuel.sosa@ulpgc.es.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsUric acid has been associated with several metabolic conditions, including bone diseases. Our objective here was to consider the relationship between serum uric acid levels and various bone parameters (bone mineral density, ultrasonographic parameters, vitamin D, PTH and serum calcium), as well as the prevalence and risk of fragility fracture.

methodsAn observational and cross-sectional study carried out on 679 postmenopausal women, classified into 3 groups according to their serum uric acid levels, in whom bone densitometry, calcaneus ultrasounds, PTH, vitamin D and serum calcium analysis were done. Bone fractures were collected through the clinical history and lateral spinal X-ray.

resultsHigher uric acid levels were found in women with older age, high BMI, diabetes, and high blood pressure. Higher levels of PTH and serum calcium were also observed, but did not effect on vitamin D. Serum uric acid was positively related to densitometric and ultrasonic parameters and negatively associated with vertebral fractures.

conclusionsIn the population of postmenopausal women studied, sUA levels were correlated with BMD, BUA, and QUI-Stiffness, and this correlation was independent of age and BMI. In addition, sUA was associated with a decrease in vertebral fractures. These results imply a beneficial influence of sUA on bone metabolism, with both a quantitative and qualitative positive effect, reflected in the lower prevalence of vertebral fractures.

Indexed as

Bone DensityPostmenopauseUric AcidAgedCalciumCross-Sectional StudiesFemaleFractures, BoneHumansMiddle AgedOsteoporosis, PostmenopausalParathyroid HormoneRisk FactorsSpinal FracturesUltrasonographyVitamin DCalciumParathyroid HormoneUric AcidVitamin DBone mineral densityCalcaneus ultrasoundsFragility fracturesUric acid

Identifiers

PMID39085733
PMCPMC11291523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.